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Abstract
DNA methylation may regulate gene expression by re-
stricting the access of transcription factors. We have 
previously demonstrated that GATA-1 regulates the 
transcription of the CCR3 gene by dynamically inter-
acting with both positively and negatively acting GATA 
elements of high affinity binding in the proximal pro-
moter region including exon 1. Exon 1 has three CpG 
sites, two of which are positioned at the negatively act-
ing GATA elements. We hypothesized that the methyl-
ation of these two CpGs sites might preclude GATA-1 
binding to the negatively acting GATA elements and, 
as a result, increase the availability of GATA-1 to the 
positively acting GATA element, thereby contributing 
to an increase in GATA-1-mediated transcription of the 
gene. To this end, we determined the methylation of the 
three CpG sites by bisulfate pyrosequencing in periph-
eral blood eosinophils, cord blood (CB)-derived eosi-
nophils, PBMCs, and cell lines that vary in CCR3 mRNA 
expression. Our results demonstrated that methyl-
ation of CpG sites at the negatively acting GATA ele-
ments severely reduced GATA-1 binding and aug-
mented transcription activity in vitro. In agreement, 
methylation of these CpG sites positively correlated 
with CCR3 mRNA expression in the primary cells and 
cell lines examined. Interestingly, methylation pat-
terns of these three CpG sites in CB-derived eosino-
phils  mostly  resembled  those  in  peripheral  blood 
eosinophils. These results suggest that methylation of 
CpG sites at the GATA elements in the regulatory re-
gions fine-tunes CCR3 transcription. 
Keywords: DNA methylation; eosinophils; GATA-1; 
receptors, CCR3; transcription factor; transcriptional 
activation 
Introduction
CCR3 is constitutively expressed at high levels in 
eosinophils with 16,000-60,000 receptors per cell; it 
serves as the primary chemokine receptor 
responsible for eosinophil recruitment to inflamed 
tissues (Daugherty et al., 1996; Kitaura et al., 1996; 
Ponath et al., 1996). CCR3 is also expressed on 
prominent allergic inflammatory cells, including Th2 
helper cells (Sallusto et al., 1997) and mast cells 
(Forsythe and Befus, 2003). The restricted expression 
of CCR3 leads to a notion that it plays an integral 
role in the pathogenesis of allergic diseases 
including asthma, allergic dermatitis, and allergic 
rhinitis. Furthermore, as airway epithelial cells 
express functional CCR3, this chemokine receptor 
is postulated to play other roles beyond trafficking of 
the migratory cells, such as airway remodeling 
(Stellato et al., 2001; Beck et al., 2006). Thus, the 
exact role of CCR3, which is expressed on a variety 
of cell types, in the development of allergic 
symptoms remains to be established. The interest in 
CCR3 as a therapeutic target led to the 
development of a number of small molecule Methylation of CCR3 gene     269
antagonists, some of which have been studied in 
clinical trials against eosinophil-associated diseases 
(Willems and Ijzerman, 2010). The pathological role 
of eosinophils has been challenged with the findings 
that anti-interleukin-5 (IL-5) antibody for anti-eosinophil 
therapy had little effect on clinical parameters seen 
in mild-to-moderate asthma (Leckie et al., 2000; 
Flood-Page et al., 2003). However, this therapy has 
recently been shown to be effective for the treatment 
of a small group of patients with eosinophilic asthma 
(Haldar et al., 2009; Nair et al., 2009). In this sense, 
it has been suggested that targeting both CCR3 and 
IL-5 might be a more effective means in reducing 
eosinophil recruitment and function (Rådinger and 
Lötvall, 2009).
    CCR3 expression is mainly regulated at the 
transcriptional level. The critical sequence that is 
responsible for transcriptional regulation of CCR3 
has been mapped to exon 1 and its flanking 
sequences (Zimmerman et al., 2000; Scotet et al., 
2001; Vijh et al., 2002; Zimmerman et al., 2005). 
This sequence includes binding elements for 
GATA-1, acute-myeloid leukemia-1 (AML-1), PU.1, 
and the CCAAT enhancer binding protein, most of 
which are also known to participate in the regulation 
of eosinophil development/differentiation in a 
combinatorial manner (Zhang et al., 1997; Nerlov 
and Graf, 1998; Hirasawa et al., 2002; Iwama et al., 
2002; McNagny and Graf, 2002), suggesting an 
intimate relationship between CCR3 expression and 
eosinophil development. Among these, GATA-1 is 
considered the most critical transcription factor for 
both eosinophil development and eosinophil-specific 
gene expression. GATA-1 binds to a GATA site within 
the murine GATA-1 promoter with a high affinity, and 
removal of the binding site selectively abolishes the 
eosinophil lineage (Yu et al., 2002). GATA-1 
transactivates eosinophil-specific genes, including 
major basic protein (MBP), Charcot-Leyden crystal 
protein, and eosinophil-derived neurotoxin, by binding 
to functional GATA elements in their promoters 
(Dyer and Rosenberg, 2000; Du et al., 2002; Qiu et 
al., 2009). Involvement of GATA-1 in CCR3 
transcription has been demonstrated (Zimmerman 
et al., 2005) and subsequently leads to postulation 
of a double-GATA element as a key regulatory 
element of GATA-1-mediated transcription of 
eosinophil-specific genes, including human CCR3, 
interleukin-5 receptor alpha, MBP and GATA-1 
genes (Rothenberg and Hogan, 2006). We have 
recently analyzed GATA-1-mediated transcription of 
CCR3 at the molecular level (Kim et al., 2010). Of 
five GATA elements in exon 1 of CCR3, the first 
GATA element is solely responsible for 
GATA-1-mediated transctivation. The second and 
third GATA elements have minimal effects on 
reporter activity, with low binding affinity for GATA-1. 
In contrast, the fourth and fifth GATA elements play 
an inhibitory role in transactivation, with a high 
affinity binding for GATA-1 comparable to that of the 
first GATA element. Thus, it appears that the 
positively acting GATA element exerts its effect in 
conjunction with the negatively acting GATA elements 
for GATA-1-mediated transcriptional control of CCR3. 
    In  mammals,  the  majority  of  DNA  methylation 
occurs symmetrically on the cytosine residues on 
both strands of the CpG dinucleotide. DNA 
methylation can directly inhibit promoter function by 
sterically hindering the binding of transcription 
factors and indirectly affecting the chromatin state 
through the recruitment of methyl-CpG-binding 
proteins, such as MeCP2 (Klose and Bird, 2006). 
CpG-rich promoters demonstrate very low levels of 
CpG methylation at the transcription start sites, 
while CpG-poor promoters exhibit markedly higher 
levels of CpG methylation (Zhang et al., 2009). CpG 
methylation is an essential feature of development, 
as it reprograms the transcriptional activation and 
inactivation of genes during development (Okano et 
al., 1999; Li, 2002; Reik, 2007). Methylation of CpGs 
serves as dynamic epigenetic marks that undergo 
extensive change during cellular differentiation. 
Promoters with low CpG density are associated with 
developmentally regulated genes, while promoters 
with high CpG density are associated with 
constitutively expressed genes (Meissner et al., 
2008). It has recently been demonstrated that DNA 
methylation plays a direct role in lineage restriction 
during hematopoiesis process, and alterations in 
expression of lineage-specific genes accompany 
graded changes in DNA methylation within those 
genes in a differentiation stage-specific manner 
during lineage specification (Broske et al., 2009; 
Trowbridge et al., 2009).
    CCR3 expression is subject to epigenetic regulation. 
Treatment with histone deacetylase inhibitors 
results in induction of CCR3 mRNA in myeloid cell 
lines (Tiffany et al., 1998; Ishihara et al., 2007; Kim 
et al., 2010). However, whether DNA methylation is 
involved in expression of the gene has not been 
reported. Close examination shows that exon 1 of 
CCR3 includes three CpG sites, two of which are 
located in the regions immediately flanking the 
fourth GATA element and within the fifth GATA 
element, respectively. As the fourth and fifth GATA 
elements may act as sinkers of GATA-1 due to their 
high affinity binding for GATA-1 against the first GATA 
element that is responsible for transactivation, 
methylation of these sites can affect GATA-1-mediated 
CCR3 transcription. These observations prompted 
us to investigate whether these CpG sites could be 
methylated in primary eosinophils and a variety of 270    Exp. Mol. Med. Vol. 44(4), 268-280, 2012
Figure 1. The sequences of exon 1 
of CCR3 and the probes for EMSA. 
(A) Exon 1 is 161 base pairs in 
length. Numbers on the right are 
designated based on the longest 
exon (Vijh et al., 2002). Open and 
closed boxes represent CREB and 
GATA elements, respectively. AML-1 
elements are indicated by a double 
line. Asterisks indicate CpG sites, 
one of which is located within the 
CREB element, and the other two 
are located in regions flanking and 
within GATA elements, respectively. 
(B) Three probe sequences for 
EMSA are indicated. Probe 1 in-
cludes two CpG sites, while probe 2 
and probe 3 include a single CpG 
site.
cell lines that greatly vary in CCR3 mRNA 
expression and whether methylation of these sites 
influences GATA-1 binding and the resulting CCR3 
transcription.
Results
CpG sites at GATA elements in the regulatory region 
of CCR3 gene
The CCR3 gene is located on chromosome 3p21 
and consists of at least four exons (Vijh et al., 2002). 
This gene does not have a CpG island throughout 
its entire sequence of promoter, exons, and introns, 
as judged on the basis of its size, GC content, and 
CG dinucleotide frequency (Zhao and Han, 2009), 
thus indicating a CpG-poor promoter or regulatory 
region. The most critical regulatory sequences for 
CCR3 gene transcription reside in exon 1 of 161 
base pairs in length (Vijh et al., 2002), which includes 
five GATA sites, two AML-1 sites, and a CREB site 
(Figure 1). The fourth and the fifth GATA sites in 
exon 1 are claimed to constitute a double-GATA site 
as a key element that dictates GATA-1-mediated 
transcription of many eosinophil-specific genes 
(Rothenberg and Hogan, 2006). However, our previous 
study using a reporter plasmid assay in K562 cells 
demonstrated that the first GATA site is solely 
responsible for GATA-1-mediated transactivation of 
CCR3, while the fourth and fifth GATA sites play 
inhibitory roles in CCR3 transcription, with high 
affinity binding for GATA-1 comparable to that of the 
first GATA element (Kim et al., 2010).The differential 
contributions of these GATA sites to CCR3 trans-
cription were almost exactly duplicated in A549 cells 
(Supplemental Data Figure S1), and GATA-1 bound 
to sequences in exon 1 of CCR3 genes, as analyzed 
by ChIP assay (Supplemental Data Figure S2). 
Close examination revealed that there are three 
CpG sites in exon 1. One is located within the CREB 
binding element and the other two reside in the 
regions immediately flanking the fourth GATA site 
and within fifth GATA site (Figure 1). The negative 
regulation of the fourth and fifth GATA sites in CCR3 
transcription led to the hypothesis that methylation 
of these two sites might limit GATA-1 binding and 
redirect available GATA-1 to the positive GATA 
element, resulting in an increase in GATA-1-mediated 
transcription of CCR3. 
Methylation of three CpG sites in exon 1 of CCR3 in 
peripheral blood eosinophils, CB-derived 
eosinophils, and a panel of cell lines 
The methylation of the CpG sites in exon 1 was 
quantitatively determined by pyrosequencing following 
bisulfite treatment of genomic DNA from peripheral 
blood eosinophils (Figure 2 and Table 1). Each CpG 
site displayed a characteristic methylation pattern 
with slight variation among donors: methylation of 
the CpG site at the CREB site was low, the 4th GATA 
site was intermediately-to-highly methylated, and 
the 5th GATA site was highly methylated. We also 
determined the methylation of these CpG sites in 
human cord blood (CB)-derived eosinophils, which Methylation of CCR3 gene     271
Figure 2. DNA methylation of CpG sites in exon 1 analyzed by bisulfite pyrosequencing. The panels represent methylation status of CpG sites in exon 1 
of the CCR3 gene in peripheral blood eosinophils and CB-derived eosinophils. The positions of CpG sites are indicated on the upper histograms, and the 
methylation levels are presented on the top of each histogram. In parenthesis, the CpG sites at +31, +103, and +118 are located in the CREB, fourth 
GATA, and fifth GATA elements, respectively. 
are shown to express significant levels of CCR3 
mRNA (Lamkhioued et al., 2003; Kang et al., 2005). 
To this end, CD34
+ cells were purified to 95% 
homogeneity by MACS and were cultured in the 
presence of a cytokine cocktail for 24 days. CD34
+ 
cells gradually disappeared, while MBP-positive 
cells appeared as early as day 4 (data not shown), 
steadily increased, and attained a greater than 90% 
proportionality at day 18 (Figure 3A). Immun-
ofluorescence analysis showed that nearly all 
cultured cells had a high density of MBP molecules 
in their cytoplasmic granules at day 24 (Figure 3B), 
confirming that CB cells are a suitable in vitro model 
of eosinophils. CB-derived eosinophils had low CpG 
methylation at the CREB site (2-4%), intermediate- 
to-high methylation at the fourth GATA element 
(71-84%), and high methylation at the fifth GATA 
element (82-90%) (Figure 2). Thus, this methylation 
pattern was strikingly similar to what were observed 
in peripheral blood eosinophils (Figure 2). Methylation 
of the the CpG at the CREB site in PBMC was at 
intermediate level (47-58%), while the fourth and fifth 
GATA sites were highly methylated, as in peripheral 
blood eosinophils and CB-derived eosinophils (Table 
1). We further analyzed the methylation statuses of 
a panel of cell lines (Table 1). The CpG site at the 272    Exp. Mol. Med. Vol. 44(4), 268-280, 2012
Cells Donor
Methylation (%) CCR3 mRNA
CREB (+31)
a 4th GATA (+103)
a 5th GATA (+118)
a ΔCt
Peripheral blood eosinophils
CB‐derived
eosinophils
(day 24)
PBMC
#1
#2
#3
#1
#2
#3
#1
#2
#3
3
11
13
3
4
2
47
58
55
40
76
80
71
74
86
74
82
77
68
87
89
82
84
90
81
88
85
-5.0 ± 0.15
-5.2 ± 0.20
-5.3 ± 0.04
0.6 ± 0.12
0.1 ± 0.12
-0.2 ± 0.12
0.9 ± 0.40
1.5 ± 0.16
1.6 ± 0.25
U937
Jurkat
NCI‐H292
A549
293T
EoL‐1
HL‐60
K562
85
90
89
82
84
78
2
2
90
86
85
57
32
97
12
11
96
89
85
64
32
98
16
14
9.4 ± 1.82
b
12.8 ± 0.44
b
13.2 ± 1.02
b
14.1 ± 3.06
b
14.9 ± 1.99
b
16.2 ± 0.01
b
16.6 ± 0.62
b
19.2 ± 1.30
b
aNumbers indicate positions of CpG sites from the transcription start site; 
bCCR3 mRNA level in cell lines were determined in three independent experi-
ments performed in triplicate.
Table 1. Methylation status of CpG sites in exon 1 of CCR3 and CCR3 mRNA expression level
Figure 3. Production of CB-derived eosinophils. (A) CD34
+ cells were 
cultured with a cytokine cocktail for the days indicated, as described in 
Materials and Methods. Expressions of CD34 and MBP proteins were 
analyzed by FACS. The results represent the mean ± SEM of three to 
seven independent experiments. (B) MBP expression of developing eosi-
nophils at day 0 and 24 was visualized with a fluorescence microscope. 
DAPI and MBP stains are shown in blue and green, respectively. 
CREB element was hypermethylated in five cell 
lines, including U937, Jurkat, NCI-H292, A549, and 
293T, while the CpG site was hypomethylated in two 
myeloid cell lines, including K562 and HL-60 cells. 
The CpG methylation at the fourth and fifth GATA 
elements was high in U937, Jurkat, and NCI-H292 
cells, intermediate in A549 and 293T cells, and low 
in K562 and HL-60 cells. Thus, none of these cell 
lines were similar to peripheral blood eosinophils or 
CB-derived eosinophils in the methylation patterns 
of these CpG sites. It was of interest to note that 
HL-60 cells, which are converted to eosinophilic 
cells with induced expression of surface CCR3 in 
the presence of histone deacetylase inhibitors 
(Tiffany  et al., 1998; Ishihara et al., 2007), had 
entirely different methylation patterns at the three 
sites from peripheral blood eosinophils and 
CB-derived eosinophils (Table 1). 
Correlation of CCR3 mRNA expression with CpG 
methylation 
To explore correlation between CCR3 mRNA ex-
pression and methylation of these CpG sites 
quantitative real-time PCR of CCR3 mRNA was 
carried out whose levels were expressed as ΔCT 
(CCR3 CT - GAPDH CT) following real-time PCR. 
The results showed that CCR3 mRNA was ex-
pressed at the highest level in peripheral blood 
eosinophils, followed by CB-derived eosinophils 
and PBMCs. U937 and Jurkat cells expressed Methylation of CCR3 gene     273
Figure 4. Correlation of methylation of CpG sites at GATA elements with 
CCR3 mRNA level. The levels of methylation in the fourth (A) and fifth 
(B) GATA sites were determined using bisulfite pyrosequencing, and 
CCR3 mRNA expression was measured by real-time PCR, as described 
in Methods. The correlation between the level of CCR3 mRNA ex-
pression and the degree of methylation on CpG was analyzed using 
Pearson correlation analysis.
Figure 5. EMSA using probes with methylated and unmethylated CpG 
sites. (A) Unmethylated (U) and methylated probe 1 (M), which includes 
the two CpG sites as depicted in Figure 1, were incubated with nuclear 
extracts (4 mg) from K562 cells in the presence or absence of indicated 
competitors (50 ×). Specificity of GATA-1 binding was confirmed by pre-
incubation with specific anti-GATA-1 (S) and control antibody (C). Arrow 
head and arrow indicate protein-DNA complex and supershift, 
respectively. (B) To examine binding efficiency, increasing amounts (0.5, 
1, 2, and 4 μg) of nuclear extracts (NE) were incubated with un-
methylated and methylated probe 1. (C) To determine which methylated 
CpG contributed to the inefficient binding of methylated probe 1 to 
GATA-1, probes 2 and 3 containing individual CpG sites were incubated 
with nuclear extracts and compared with probe 1 for GATA-1 binding. (D) 
To determine the difference in binding affinity, binding of a radiolabeled 
unmethylated probe 1 was titrated with cold unmethylated and methy-
lated probes. 
CCR3 mRNA at lower levels than did peripheral 
blood eosinophils and CB-derived eosinophils but at 
higher levels than three epithelial cell lines. 
Interestingly, two myeloid cell lines, K562 and 
HL-60, expressed negligible levels of CCR3 mRNA 
in an undifferentiated state. The ΔCT values for 
CCR3 mRNA in all the cell types tested correlated 
with the levels of methylation at both the fourth and 
the fifth GATA elements: Pearson correlation 
coefficients (r) were -0.543 (P =0.030) and -0.694 
(P =0.003) at the fourth and the fifth GATA elements, 
respectively (Figure 4), suggesting an association of 
methylation at these CpG sites with CCR3 mRNA 
expression. 
Binding of GATA-1 to GATA elements with 
methylated CpG sites
To evaluate the effect of methylation on GATA-1 
binding, EMSA was carried out with nuclear extracts 
of K562 cells endogenously expressing a high level 
of GATA-1 (Du et al., 2002). The fourth and fifth 
GATA elements in the exon 1 sequence contain 
CpGs, 5'-tatccg-3' for fourth GATA and 5'-tatcg-3' for 
fifth GATA, where underlined text denotes the GATA 
elements and bold text denotes CpG sites (Figure 
1). We synthesized oligonucleotides in which the dC 
bases at +103 and +118 were converted to 
deoxymethylcytosine, with the complementary 
antisense oligonucleotides also methylated at the 
corresponding dCs to those in the sense strands. 
Methylated probe 1 bound to GATA-1 more weakly 
than the unmethylated counterpart (lane 4 versus 
lane 1 in Figure 5A). The specificity of GATA-1 
binding was confirmed by formation of a supershift 
upon incubation with anti-GATA-1, even though the 
methylated probe bound very weakly (lanes 7 versus 
9 in Figure 5A). The difference in the binding affinity 
of these two oligonucleotides was evident by the 
extent of binding with increasing amounts of nuclear 
extracts (Figure 5B). Probe 2, which contained a 
CpG site at a region immediately flanking the fourth 
GATA element, showed slightly reduced binding 
upon methylation (lane 1 versus lane 2 in Figure 5C), 
while probe 3, which contained a CpG site within the 
fifth GATA element, exhibited nearly no binding 
upon methylation (lane 3 versus lane 4 in Figure 
5C). Therefore, the inability of the methylated CpG 
within the fifth GATA element to bind GATA-1 greatly 
contributed to the significantly reduced binding of 
methylated probe 1 that contained most of the 
sequences of both probe 2 and probe 3. In addition, 
the severe impairment of GATA-1 binding to the 
methylated fifth GATA element is in line with more 
significant and obvious correlation of the methylated 274    Exp. Mol. Med. Vol. 44(4), 268-280, 2012
Figure 6. Transcription activity of exon 1 with unmethylated and methy-
lated CpG sites. (A) Constructs of exon 1 with methylated or un-
methylated CpG sites at GATA elements. Methylated exon 1 was gen-
erated by in vitro methylation. Mut4-5, in which two TATC sequences 
were replaced with GCGA, which was expected to have an equivalent ef-
fect to those of methylated GATA elements, was used as a reference. 
Mut1, whose transcription activity was previously shown to be reduced 
by more than half compared with that of an unmutated version (Kim et 
al., 2010), was also used as a reference to validate this assay. Filled box-
es represent GATA elements, and open and closed lollipops represent 
unmethylated and methylated CpG sites, respectively. U and M indicate 
unmethylated and methylated exon 1, respectively. (B) Varying concen-
trations of the unmethylated exon 1 fragment were ligated to a pGL3 ba-
sic vector. The whole ligation mixture was then transfected into K562 
cells. Transfection efficiency was normalized by co-transfected renilla lu-
ciferase activity. The transcription activities were determined as relative 
values (%) compared to the transcription activity of the ligation mixture 
with the molar ratio of 5 unmethylated exon 1 (insert) to 1 vector. The da-
ta were expressed as mean ± SEM of two independent experiments 
performed in triplicate. (C) Methylated and unmethylated exon 1 were li-
gated with pGL3 basic vector (5:1 ratio), and their effects on transcription 
activity were determined. Transcription activity of methylated exon 1 was 
expressed relative to that of unmethylated exon 1, which was assumed 
to be 100%. The results represent the mean ± SEM of six independent 
experiments performed in triplicate.
fifth GATA element with CCR3 mRNA expression 
than the methylated fourth GATA element, as seen 
in Figure 4. Competition experiments revealed that 
methylated CpG sites had an approximately 2.5-fold 
weaker affinity for GATA-1 than did the unmethylated 
sites (Figure 5D), as measured by densitiometry 
analysis. These results suggest that GATA elements 
with methylated CpGs have much lower binding 
affinity for GATA-1 in vitro compared to that of those 
with unmethylated CpGs. Next, we tested the 
differential  in vivo occupancy of GATA-1 to the 
unmethylated and methylated GATA elements in 
K562 cells and EoL-1 cells in which the GATA 
elements were hypomethylated and hypermethylated, 
respectively (Table 1). However, we observed the 
GATA-1 occupancy regardless of cell types (data 
not shown). Lack of the differential binding seems to 
be due to the fact that the current ChIP assay cannot 
discern, if any, differential binding of GATA-1 to 
these GATA sites, probably because the fourth and 
fifth GATA elements are positioned at only about 
100 base pair away from the first GATA element that 
shows a high affinity binding for GATA-1, as seen in 
previous results (Kim et al., 2010). 
Effect of methylated GATA elements on transcription 
activity in vitro 
Next, we examined the effect of the CpG sites in 
GATA elements on transcription of CCR3 using a 
reporter assay (Figure 6A). The exon 1 sequence 
was cloned into a pGL3 basic vector and then 
subjected to in vitro methylation, which methylated 
all cytosines of CpG sites in the vector as well as in 
exon 1 (Hattori et al., 2004). When the methylated 
reporter plasmid was transfected into K562 cells, it 
completely lacked luciferase activity (data not 
shown), probably because methylation of CpG sites 
other than those in exon 1 completely nullified 
transcription of the reporter plasmid. To eliminate 
the effect resulting from methylation of the vector 
sequence itself, we directly cloned the exon 1 
sequence with methylated or unmethylated CpG 
sites into the reporter plasmid. To do so, the exon 1 
sequence was PCR-amplified, digested with two 
different restriction enzymes for the subsequent 
cloning procedure, and methylated in the absence 
or presence of S-adenosylmethionine. Both 
unmethylated and methylated exon 1 sequences 
were ligated to pGL3 basic vector. The whole ligation 
mixture was then transfected into K562 cells. When 
increasing concentrations of the exon 1 fragment of 
unmethylated CpG sites were ligated, transcription 
activity of the ligation mixture increased in proportion 
to the input amount of the exon 1 sequence used as 
an insert (Figure 6B). In addition, when the exon 1 
fragment with a mutated version (mut1) of the first 
GATA site, which was shown to decrease 
transcription by more than one-half in K562 cells 
(Kim et al., 2010) and A549 cells (Supplemental 
Data Figure S1), was ligated to a pGL3 basic vector, 
its transcription activity was reduced by more than 
half compared to that of exon 1 with unmethylated 
CpG sites. These results ensure that the ligation 
mixture contains the proper recombinant plasmid for 
transcription activation. Exon 1 with methylated 
CpG sites in the GATA elements yielded a small but 
significant increase (125 ±7.5%,  P =0.049) in Methylation of CCR3 gene     275
transcription activity compared to that of unmethylated 
CpG sites. The transcription activity in the exon 1 
was comparable to that of mut4-5, in which 
5'-gatc-3' was replaced with 5'-tcga-3', presumably 
having an equivalent effect on exon 1 with 
methylated CpG in terms of inability to bind GATA-1 
(Figure 6C). This result suggests that methylation of 
CpG sites in GATA elements in exon 1 can modulate 
the transcription activity of CCR3. We also created a 
point mutant in which the CG sequence within the 
CREB element was replaced with AT so that the 
methylation effect of the CpG site, if any, would be 
removed. The mutant had no effect on the 
transcription of the CCR3 reporter plasmid (data not 
shown). 
Discussion
Exon 1, the major regulatory region for CCR3 
transcription, includes a positively acting GATA 
element that is solely responsible for GATA-1-mediated 
transcription of the gene and two negatively acting 
GATA elements that are able to suppress CCR3 
transcription  in vitro. Since the negatively acting 
GATA elements contain CpG sites, we evaluated a 
correlation between methylation of these two sites 
and CCR3 mRNA level by bisulfate-pyrosequencing 
technology and real-time PCR with cells which 
express varying CCR3 mRNA levels, including 
peripheral blood eosinophils, CB-derived eosinophils, 
PBMC, and a panel of cells lines. Primary cells, 
including peripheral blood eosinophils, CB-derived 
eosinophils, and PBMC, expressed much higher 
level of CCR3 mRNA than PBMC and seven cell 
lines tested and had high methylation at the fourth 
and fifth GATA elements. Among cell lines, U937 
and Jurkat cells, which constitutively express CCR3 
mRNA, had high methylation statuses at these two 
GATA elements. Epithelial cell lines, especially 
A549 and 293T cells, expressed lower level of 
CCR3 mRNA than U937 and Jurkat cells, and had 
intermediate level of methylation at these two GATA 
elements. In contrast, two myeloid cell lines, K562 
and HL-60 cells, which do not constitutively express 
CCR3 mRNA, exhibited little methylation (Table 1). 
Thus, DNA methylation of the two CpG sites at the 
GATA sites correlated with CCR3 mRNA expression 
in those cells. In line with the observations, the 
negatively acting GATA elements with methylated 
CpG sites had remarkably reduced binding to 
GATA-1 (Figure 5) and resulted in an increase in 
GATA-1-mediated transcription of CCR3 gene 
(Figure 6), possibly by redirecting available GATA-1 
to the positive GATA element. These results show 
correlation of CCR3 mRNA expression with 
methylation of the CpG sites. Therefore, these 
results suggest that DNA methylation of these GATA 
elements may serve as an important epigenetic 
component of CCR3 transcription in vivo. 
    Despite the association of methylation of the CpG 
sites at GATA elements in the regulatory region of 
CCR3 with its transcription (Figure 4), the methylation 
effect on CCR3 transcription was significant but 
modest (Figure 6C). The reason for the modest 
increase appears to be largely attributed to the fact 
that the negatively acting GATA elements themselves 
do not influence CCR3 transcription as strongly as 
does the positively acting GATA element. In fact, a 
point mutant of the positively acting GATA element 
(Supplemental Data) and a mutant missing the GATA 
element exhibited severely impaired transcription 
(Kim et al., 2010), whereas a double mutant that 
disrupts both negatively acting GATA elements 
affected transcription in the reporter assay, but its 
effect was not as great as that of the positively 
acting GATA element (Figure 6C). In this context, 
methylation of CpG sites at the negatively acting 
GATA elements, while being thought to have an 
equivalent effect to the double mutant, is not likely to 
have a profound effect on CCR3 transcription in the 
cell, unlike the mutant lacking the positively acting 
GATA element. 
    GATA sequences and the complementary TATC 
sequences occur abundantly in the genome, GATA 
consensus sequences are found in the promoters 
and enhancers of many genes, and increasing 
numbers of GATA-1 target genes are being identified. 
They include genes that are indispensable for 
erythrocyte differentiation and functions, notably 
globin genes (Ferreira et al., 2005). DNA methylation 
ubiquitously occurs in globin gene clusters (Van der 
Ploeg and Flavell, 1980) and serves as a dominant 
mechanism to repress some globin genes (Goren et 
al., 2006). In addition, the regulatory regions of 
eosinophil-specific genes contain functional GATA 
elements (Dyer and Rosenberg, 2000; Du et al., 
2002; Qiu et al., 2009), although methylation within 
these elements is not determined. Our results show 
considerably reduced binding affinity of GATA-1 for 
the methylated GATA element (Figure 5). These 
data suggest that if methylation of a CpG site within 
a GATA element exerts a crucial function for 
GATA-1-mediated transcription, methylation of the 
GATA element may greatly affect transcription of the 
gene. Many transcription factors are known to bind 
CpG-containing sequences, and most of them fail to 
bind and have reduced activity when the CpG site is 
methylated. These include CREB (Kim and Leonard, 
2007), Myc (Prendergast et al., 1991; Perini et al., 
2005), USF-1 (Aoki et al., 2008), AP-2 (Comb and 
Goodman, 1990), and CTCF (Bell and Felsenfeld, 276    Exp. Mol. Med. Vol. 44(4), 268-280, 2012
2000). In contrast, other transcription factors, such 
as Sp1 or CAAT box-binding transcription factor 
(CTF), are able to bind to their binding elements 
regardless of methylation (Holler et al., 1988; 
Hantusch et al., 2007; Sunahori et al., 2009). Our 
results reveal that GATA-1 is a transcription factors 
sensitive to DNA methylation for binding and activity. 
Although such genes whose transcriptions are 
affected by DNA methylation at GATA elements are 
yet to be identified, the abundant occurrence of 
GATA consensus sequences in the genome raises 
the possibility that genes with GATA elements 
functioning as crucial cis-acting sequences may be 
transcriptionally regulated in a methylation-dependent 
manner. 
    One  intriguing  observation  is  that  the  in vitro 
differentiated eosinophils resemble peripheral blood 
eosinophils not only in a cellular phenotype (MBP 
expression level), but also in the methylation statuses 
of all the three CpG sites in exon 1 of CCR3. None of 
the cell lines, including eosinophilic cell line HL-60, 
were similar to terminally-differentiated CB-derived 
eosinophils in methylation pattern (Table 1). It is 
speculated that eosinophil progenitors with charac-
teristic methylation statuses in these CpG sites 
might exist in an extremely small fraction within 
CD34
+ cell population. The methylation pattern would 
actually remain unaltered throughout eosinophil 
development/differentiation, because the eosinophil 
progenitors selectively expand without changes in 
methylation and become a predominant population 
in the culture conditions favoring generation of 
eosinophils. Alternatively, the methylation pattern is 
progressively altered to become that of peripheral 
blood eosinophil at a single cell basis during 
eosinophil development/differentiation. It has recently 
been reported that modulation of CpG methylation 
occurs during lineage-specific differentiation in 
hematopietic cells. A notable instance, the myelo-
peroxidase gene, whose product serves as a 
marker for neutrophils, becomes progressively 
hypomethylated with upregulated expression during 
myeloid specification from multipotent progenitor to 
granulocyte/macrophage progenitor (Ji et al., 2010). 
Our results suggest that methylation of these CpG 
sites may serve as epigenetic marks during 
eosinophil development and differentiation, and it is 
likely to be one of the inherent elements accompanied 
with eosinophilopoiesis.
    CB cells have provided a well-defined model to 
study eosinophil development and function. The 
parallel DNA methylation pattern of the CCR3 
regulatory region between CB-derived eosinophils 
and peripheral blood eosinophils merits further 
investigation as to whether the coincidence extends 
to other well-known eosinophil-specific genes such 
as MBP, eosinophil peroxidase, eosinophil-derived 
neurotoxin, and eosinophil cationic protein. Analysis 
of CpGness shows that all of these genes have 
CpG-poor sequences at their proximal promoter 
regions, like the CCR3 gene. Furthermore, as gene 
microarray analysis of bone marrow-derived murine 
eosinophils failed to identify critical regulators that 
play a key role in eosinophil commitment and 
differentiation (Bystrom et al., 2004), analysis of a 
comprehensive methylation map of CB-derived 
eosinophils might help the understanding of epigenetic 
plasticity accompanying eosinophil restriction.
Methods
Ethics statement
Written informed consent was obtained from all subjects. 
The protocols used in this study were approved by the 
Soonchunhyang Bucheon Hospital’s ethics committee 
(SCHBC-IRB-06-04).
Cell culture 
A549 and HL-60 cells were purchased from Korean Cell 
Line Bank (Seoul, Korea), and K562, Jurkat, U937, 
NCI-H292, and 293T cells were obtained from ATCC 
(Manassas, VA). Human lung epithelial cells, A549 and 
NCI-H292, U937 cells, Jukat cells, HL-60 cells, and K562 
cells were maintained in RPMI 1640 medium (Welgene, 
Seoul, Korea), and human embryo kidney 293T cells were 
maintained in DMEM (Welgene). All growth media were 
supplemented with 10% FBS, penicillin (100 U/ml), and 
streptomycin (100 μg/ml). Peripheral blood eosinophils 
were isolated from slightly atopic individuals. After RBC 
had been precipitated in 6% dextran-dextrose in 0.1 M 
EDTA (pH 7.4), the leukocyte-rich cell suspension was lay-
ered on a Percoll solution (1.070 g/ml) and centrifuged at 
3,500 ×rpm for 30 min at 4°C. Enriched eosinophil frac-
tions were incubated with anti-CD16 monoclonal anti-
body-conjugated microbeads (Miltenyi Biotec, Auburn, 
CA), and contaminating neutrophils were removed through 
negative selection using a MACS (BD PharMingen, San 
Diego, CA). Peripheral blood mononuclear cells were sep-
arated from blood obtained from healthy donors by den-
sity-gradient centrifugation over Ficoll-Paque Premium 
1.073 (density, 1.077 g/ml, GE Healthcare, Uppsala, 
Sweden). CD34
+ cells were immunomagnetically purified 
from human cord blood (CB) mononuclear cells using a 
MACS CD34
+ microbead kit (Miltenyi Biotec). CD34
+ cells 
were seeded in 24-well plates at 1 ×10
5 cells/well. The 
cells were cultured in IMDM (Welgene) containing 10% 
FBS, 100 U/ml penicillin, 100 μg/ml streptomycin supple-
mented with a cytokine cocktail of SCF (50 ng/ml), FLT-3L 
(50 ng/ml), GM-CSF (10 ng/ml), IL-3 (10 ng/ml), and IL-5 
(10 ng/ml) for 6 d. Cells were then collected, split into 
12-well plates at 1 ×10
6 cells/well in medium supplemented 
with IL-3 and IL-5, incubated with a half medium change 
for an additional 6 d, and incubated in medium supple-
mented with IL-5 for up to an additional 12 d with half me-Methylation of CCR3 gene     277
dium changes every three day. 
Flow cytometry
To determine MBP and CD34 expressions, cells were 
stained with an anti-human MBP (BD Pharmingen, San 
Diego, CA) or PE-conjugated anti-human CD34 antibody 
(BD Pharmingen). Isotype-matched antibody was also 
used to stain the cells. Cells stained with anti-human MBP 
were then incubated with a PE-conjugated anti-mouse IgG1 
antibody (BD Pharmingen). Stained cells were analyzed by 
a FACSCaribur flow cytometer, and data analysis was per-
formed using CellQuest Software (Becton Dickinson, San 
Jose, CA). 
Bisulfite pyrosequencing 
The exon 1 sequence of CCR3 was amplified using the for-
ward primer and the biotinylated reverse primer designed 
by PSQ Assay Design (Biotage AB, Uppsala, Sweden). 
The primers for amplification were: for the CREB (+31) re-
gion, the forward primer was 5'-TGTTTGTGATTTGATGG 
TATTT-3' and the reverse primer was 5' (biotin)-AACTTC 
TATTATATTTCRATAAATTCTTACC-3'; for GATA (+103 and 
+118) elements, the forward primer was 5' (biotin)-GTAGG 
TATTATTGGTTTTTTTGTG-3' and the reverse primer was 
5'-CCTCCTAAATCCAAAAACACT-3'. Twenty nanograms of 
genomic DNA was modified with sodium bisulfite using the 
EZ DNA Methylation kit (ZYMO Research, Irvine, CA) ac-
cording to the manufacturer’s instructions. Bisulfite-modi-
fied DNA was amplified in a 25 μl reaction with the primer 
set and 5 units of Taq polymerase (Solgent Co., Daejeon, 
Korea). The thermocycler program was as follows: 95
oC for 
10 min; 40 cycles consisting of 95
oC for 45 s, 55
oC for 35 
s, and 72
oC for 60 s; 72
oC for 10 min; and a hold at 4
oC. 
For verification, the PCR products were visualized on a 
1.5% agarose gel with ethidium bromide staining. 
Pyrosequencing reactions were carried out with sequenc-
ing primers on the PSQ HS 96A System (Biotage AB) ac-
cording to the manufacturer’s specifications. The methyl-
ation indexes of each gene promoter and of each sample 
were calculated as the average value of 
mC (
mC+C) for all 
examined CpGs in the target region. Statistical correlations 
between MtI and the clinical variables recorded were cal-
culated using SPSS. The primers for sequencing the 
CREB (+31) region were 5'-ATTTTTGTTTTAGGAGTG-3'; 
at GATA (+103 and +118) elements, 5'-TCTTCTAAATAA 
AAACTTCTATTATA-3'.
In vitro methylation and luciferase reporter assay 
The exon 1 region of the CCR3 gene (-18/+179 relative to 
the transcription start site) was amplified using Primestar 
high fidelity Taq DNA polymerase (Takara, Shinga, Japan) 
and forward and reverse primers containing Xho I and Hind 
III restriction sites at the 5' ends, respectively. PCR primer 
sequences were previously described (Kim et al., 2010). 
PCR products were digested with Xho I and Hind III, and 
then the resulting Xho I-Hind III fragment was incubated 
with 24 units of M.SssI methylase (New England Biolabs, 
Ipswich, MA) in the presence (methylated) or absence 
(mock-methylated) of S-adenosylmethionine at 37
oC for 4 
h. DNA methylation status was confirmed by digestion with 
methylation-sensitive Hpa II (New England Biolabs) (Kim et 
al., 2011). Methylated and mock-methylated DNA was li-
gated to pGL3-basic vector (Promega, Madison, WI). The 
total ligation mixture was purified with a PCR purification kit 
(Macherey-Nagel, Duren, Germany) and transfected with 
pRL-TK (Promega) vector using Lipofectamine 2000 
(Invitrogen Life Technologies, Carlsbad, CA). After 36 h, lu-
ciferase activity was measured using the Dual-Luciferase 
Reporter Assay System (Promega), and transfection effi-
ciency was normalized to renilla luciferase activity. 
Electrophoretic mobility shift assay (EMSA)
Nuclear extraction and EMSA were performed as pre-
viously described (Kim et al., 2010). Methylated and un-
methylated oligonucleotides were synthesized (Bioneer 
Inc, Daejeon, Korea) and annealed with complementary 
oligonucleotides that were also methylated or un-
methylated at cytosine residues within CpG sites. Nuclear 
extracts of K562 cells were incubated with 
32P-labeled oli-
gonucleotide probes in binding buffer (50 mM Tris-Cl [pH 
7.5], 20% glycerol, 5 mM MgCl2, 2.5 mM EDTA, 2.5 mM DTT, 
250 mM NaCl, and 0.25 mg/ml poly [dI-dC]ㆍpoly [dI-dC]). 
For supershift analysis, nuclear extracts were incubated 
with anti-GATA-1 (M-20, Santa Cruz Biotechnology, Santa 
Cruz, CA) or control antibody (Sigma-Aldrich, St. Louis, 
MO), followed by radiolabeled probes. The DNA-protein 
complexes were resolved on 6% nondenaturing poly-
acrylamide gels. 
Immunofluorescence analysis
Cytospin was prepared from CD34
+ cells and cultured with 
a cytokine cocktail for 24 days. Cells were fixed with 4% 
paraformaldehyde (Sigma-Aldrich) for 10 min, washed with 
PBS, and permeabilized with 0.1% saponin in PBS for 10 
min. After washing three times with PBS, the cells were in-
cubated in blocking buffer (3% BSA in PBS) for 1 h and 
then stained with FITC-conjugated anti-human MBP (BD 
Pharmingen) or FITC-conjugated anti-mouse IgG1 Ab (BD 
Pharmigen), and washed three times with PBS. All steps 
were carried out at room temperature. The cells were 
mounted in VECTASHIELD Mounting Medium with DAPI 
(Vector Laboratories, Burlingame, CA).
Real-time PCR
Total RNA was isolated using TRI reagent (Molecular 
Research Center, Cincinnati, OH) and treated with DNase I 
(Invitrogen Life Technologies). cDNA was reverse-tran-
scribed from 2 μg of total RNA using SuperScript II RNase 
Reverse Transcriptase and random hexadeoxynucleotide 
primers (Invitrogen Life Technologies). Real-time PCR was 
performed with SYBR Green (Roche, Mannheim, Germany) 
mix using the ABI 7500 Real-Time PCR system (Applied 
Biosystems). Assays were carried out in triplicate. The pri-
mer sequences were as follows: CCR3 forward primer 
5'-TCGTTCTCCCTCTGCTCG-3' and reverse primer 
5'-CACCGCCATGATGACAAA-3'; GAPDH forward primer 
5'-AGGGCTGCTTTTAACTCTGGT, and reverse primer 
5'-CCCCACTTGATTTTGGAGGGA.278    Exp. Mol. Med. Vol. 44(4), 268-280, 2012
Statistical analysis 
The data were managed and analyzed using SPSS 10.0 
software (SPSS, Inc., Chicago, IL). To compare relative re-
porter activities between experiments, we used an in-
dependent  t test. The correlation between the level of 
CCR3 mRNA expression and the degree of methylation on 
CpG was analyzed using Pearson correlation analysis. 
Statistical significance was defined at the standard 5% lev-
el with a two-tailed analysis.
Supplemental data
Supplemental data include two figures and can be found 
with this article online at http://e-emm.or.kr/article/article_files/ 
SP-44-4-03.pdf.
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